60
Participants
Start Date
June 18, 2021
Primary Completion Date
April 23, 2023
Study Completion Date
April 23, 2023
Dexmedetomidine / Ketamine / Lidocaine
Patients in this group will receive an infusion of lidocaine, ketamine, or dexmedetomidine supplemented with other intravenous analgesics and intravenous and inhaled anesthetics, as needed clinically. This includes administration of 5 mcg/kg/min of ketamine plus 0.5 - 1.0 µg/kg/hr of dexmedetomidine (Precedex) as a continuous infusion, started from induction to stop one hour before surgery is anticipated to end.
Massachusetts General Hospital, Boston
Massachusetts General Hospital
OTHER